Show simple item record

dc.contributor.authorZúñiga, Leyre
dc.contributor.authorCalvo Hernaez, Begoña
dc.date.accessioned2017-03-03T11:57:52Z
dc.date.available2017-03-03T11:57:52Z
dc.date.issued2010-05
dc.identifier.citationHospital pharmacy Europe 50(May/June) : (2010)es
dc.identifier.issn1477-1896
dc.identifier.urihttp://hdl.handle.net/10810/20854
dc.description.abstractBiotechnology represents a considerable opportunity, but also a challenge, given the complexities and risk associated with the development and manufacture of biological medicines.es
dc.language.isoenges
dc.publisherCogora Limitedes
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectbiosimilarses
dc.titleBiosimilars – the way forwardes
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© Cogora Limitedes
dc.relation.publisherversionhttp://www.hospitalpharmacyeurope.com/issues/38945es
dc.relation.publisherversionhttp://www.hospitalpharmacyeurope.com/featured-articles/biosimilars-way-forwardes
dc.departamentoesFarmacia y ciencias de los alimentoses_ES
dc.departamentoeuFarmazia eta elikagaien zientziakes_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record